Description
Herceptin (600 mg/5 mL, 1 Vial)
Description: Herceptin (trastuzumab) is a prescription medication used to treat HER2-positive breast cancer and other HER2-overexpressing cancers. It is a monoclonal antibody that specifically targets the HER2 receptor, which plays a crucial role in the growth and spread of certain cancer cells. Herceptin is typically administered as an intravenous (IV) infusion, either alone or in combination with chemotherapy agents. It is widely used in the treatment of early-stage, metastatic, and adjuvant breast cancer.
Formulation:
Strength: 600 mg per 5 mL vial
Route of Administration: Intravenous (IV) infusion
Appearance: Clear to slightly opalescent, colorless to pale yellow solution
Indications:
HER2-positive breast cancer (early-stage, metastatic, or adjuvant)
HER2-positive gastric cancer (in combination with chemotherapy)
Metastatic gastric cancer
Mechanism of Action: Herceptin targets and binds to the HER2 receptor on the surface of cancer cells, inhibiting the signaling pathways that lead to tumor growth and survival. This can lead to the destruction of cancer cells through various immune-mediated processes.
Key Points:
Strength: 600 mg/5 mL
Administration: IV infusion
Indications: HER2-positive breast cancer, HER2-positive gastric cancer
Mechanism: Inhibits HER2 receptor signaling
Side Effects: Includes fever, chills, nausea, diarrhea, fatigue, and potential heart-related issues
Storage:
Store in the refrigerator at 2°C to 8°C (36°F to 46°F)
Protect from light, and do not freeze
Note: Herceptin should be administered under the supervision of a healthcare professional. It is essential to follow your doctor’s instructions regarding dosage and administration.
Keywords:
Herceptin
Trastuzumab
HER2-positive breast cancer
HER2 receptor inhibitor
Cancer treatment
IV infusion
Monoclonal antibody
Adjuvant therapy
Metastatic breast cancer
Gastric cancer
Cancer care
Targeted therapy
Chemotherapy combination
Immune response
Reviews
There are no reviews yet.